Roche/GSK Boniva price
Executive Summary
The wholesale acquisition cost of Roche/GlaxoSmithKline's once-monthly osteoporosis agent Boniva (ibandronate) is $64.28 per tablet, comparable to the monthly cost of Merck's once-weekly Fosamax. Roche/GSK plan to launch Boniva by the end of April (1"The Pink Sheet" April 4, 2005, p. 4)...
You may also be interested in...
Roche/GSK Boniva Launch Plan Includes Reminders For Once-Monthly Dose
Roche and GlaxoSmithKline will support the launch of the osteoporosis therapy Boniva (ibandronate) with a program intended to help patients comply with the once-monthly oral dosing regimen
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.